Recent

% | $
Quotes you view appear here for quick access.

Osiris Therapeutics, Inc. Message Board

  • boardwalk97 boardwalk97 Oct 13, 2013 10:19 AM Flag

    TAM

    From another slide show Restrictive Burn
    Scarring
    $776M(3)
    40,000 hospitalized burn victims in 2012

    Pile on the billions for Grafix product- not to be concerned about recent sale of assets.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Osirs once estmated their Total Addressable Market (TAM) for the USA like this:

      Burns $150 to 300 million
      Limb Salvage $1 billion
      Diabetic Foot Ulcers (DFU) $2 billion
      Hip Revision $500 million
      Spine Fusion $900 million
      Cartilage repair $500 million
      Total $5.05 billion

      Double these numbers to include foreign Sales
      Grand total $10,1 billion

      If Osiris captures only 4% of this total market then they will have annual revenues of about $404 million. 4% seems to be the average market penetration for Wound Care companies and the top 5 do about 7% each.

      I think these numbers are very conservative! For example, there are 150 million diabetics worldwide and 25% of them will have a DFU event somtime during their lifetime. Average number of Grafix treatmens are 6 per DFU, at $2,600 each. As can be seen, just a small percentage increase in market penetration would result in a huge revenue uptick

 
OSIR
18.20-0.16(-0.87%)May 22 4:00 PMEDT